nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Remifentanil—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Remifentanil—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Remifentanil—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Remifentanil—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Remifentanil—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Remifentanil—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Remifentanil—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Remifentanil—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Remifentanil—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Remifentanil—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Remifentanil—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Remifentanil—Erythema—Prednisolone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Remifentanil—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Remifentanil—Bradycardia—Betamethasone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Remifentanil—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Remifentanil—Haemoglobin—Betamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Remifentanil—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Remifentanil—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Remifentanil—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Remifentanil—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Remifentanil—Hallucination—Dexamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Remifentanil—Hallucination—Betamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Remifentanil—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Remifentanil—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Remifentanil—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Remifentanil—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Remifentanil—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Remifentanil—Visual impairment—Betamethasone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Remifentanil—Erythema—Triamcinolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Remifentanil—Erythema—Methylprednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Remifentanil—Syncope—Prednisolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Remifentanil—Angiopathy—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Remifentanil—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Remifentanil—Convulsion—Prednisolone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Remifentanil—Hypertension—Prednisolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Remifentanil—Arrhythmia—Betamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Remifentanil—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Remifentanil—Erythema—Dexamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Remifentanil—Erythema—Betamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Remifentanil—Hallucination—Prednisone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Remifentanil—Syncope—Triamcinolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Remifentanil—Syncope—Methylprednisolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Remifentanil—Oedema—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Remifentanil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Remifentanil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Remifentanil—Shock—Prednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Remifentanil—Cough—Triamcinolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Remifentanil—Convulsion—Triamcinolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Remifentanil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Remifentanil—Hypertension—Triamcinolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Remifentanil—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Remifentanil—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Remifentanil—Flushing—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Remifentanil—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Remifentanil—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Remifentanil—Oedema—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Remifentanil—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Remifentanil—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Remifentanil—Syncope—Betamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Remifentanil—Syncope—Dexamethasone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Remifentanil—Sweating—Methotrexate—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Remifentanil—Shock—Triamcinolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Remifentanil—Shock—Methylprednisolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Remifentanil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Remifentanil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Remifentanil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Remifentanil—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Remifentanil—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Remifentanil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Remifentanil—Erythema—Prednisone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Remifentanil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Remifentanil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Remifentanil—Convulsion—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Remifentanil—Convulsion—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Remifentanil—Hypertension—Dexamethasone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Remifentanil—Hypertension—Betamethasone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Remifentanil—Anxiety—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Remifentanil—Anxiety—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Remifentanil—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00261	0.00261	CcSEcCtD
Remifentanil—Pain—Prednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Remifentanil—Oedema—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Remifentanil—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Remifentanil—Oedema—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Remifentanil—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Remifentanil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Remifentanil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Remifentanil—Anaemia—Prednisone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Remifentanil—Shock—Dexamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Remifentanil—Shock—Betamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Remifentanil—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Remifentanil—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Remifentanil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Remifentanil—Agitation—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Remifentanil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Remifentanil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Remifentanil—Tachycardia—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Remifentanil—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Remifentanil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Remifentanil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Remifentanil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Remifentanil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Remifentanil—Syncope—Prednisone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Remifentanil—Pain—Triamcinolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Remifentanil—Hypotension—Dexamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Remifentanil—Convulsion—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Remifentanil—Hypertension—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Remifentanil—Chills—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Remifentanil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Remifentanil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Remifentanil—Anxiety—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Remifentanil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Remifentanil—Erythema—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Remifentanil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Remifentanil—Urticaria—Triamcinolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Remifentanil—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Remifentanil—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Remifentanil—Oedema—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Remifentanil—Shock—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Remifentanil—Pain—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Remifentanil—Pain—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Remifentanil—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Remifentanil—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Remifentanil—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Remifentanil—Urticaria—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Remifentanil—Paraesthesia—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Remifentanil—Cough—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Remifentanil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Remifentanil—Dyspepsia—Prednisone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Remifentanil—Rash—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Remifentanil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Remifentanil—Headache—Prednisolone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Remifentanil—Constipation—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Remifentanil—Dizziness—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Remifentanil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Remifentanil—Nausea—Prednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Remifentanil—Pruritus—Betamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Remifentanil—Vomiting—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Remifentanil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Remifentanil—Rash—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Remifentanil—Rash—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Remifentanil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Remifentanil—Urticaria—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Remifentanil—Headache—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Remifentanil—Headache—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Remifentanil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Remifentanil—Dizziness—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Remifentanil—Dizziness—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Remifentanil—Nausea—Triamcinolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Remifentanil—Nausea—Methylprednisolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Remifentanil—Vomiting—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Remifentanil—Rash—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Remifentanil—Rash—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Remifentanil—Headache—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Remifentanil—Headache—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Remifentanil—Pain—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Remifentanil—Pruritus—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Remifentanil—Diarrhoea—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Remifentanil—Nausea—Betamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Remifentanil—Nausea—Dexamethasone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Remifentanil—Dizziness—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Remifentanil—Vomiting—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Remifentanil—Rash—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Remifentanil—Headache—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Remifentanil—Nausea—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Remifentanil—Rash—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Remifentanil—Headache—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Remifentanil—Nausea—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
